The Association Between Triglyceride-Glucose Index and Its Combination with Obesity Indicators and Lower Extremity Peripheral Artery Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas 9(th) edition.Diabet Res Clin Pract.2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Barnes JA, Eid MA, Creager MA, et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(8):1808–1817. doi:10.1161/ATVBAHA.120.314595
   PubMed Web of Science ®Google Scholar
• Cardoso CRL, Melo JV, Santos TRM, et al. Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc Diabetol. 2021;20(1):54. doi:10.1186/s12933-021-01249-y
   PubMed Web of Science ®Google Scholar
• Hiramoto JS, Teraa M, de Borst GJ, et al. Interventions for lower extremity peripheral artery disease. Nat Rev Cardiol. 2018;15(6):332–350. doi:10.1038/s41569-018-0005-0
   PubMed Web of Science ®Google Scholar
• Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128(12):1818–1832. doi:10.1161/CIRCRESAHA.121.318535
   PubMed Web of Science ®Google Scholar
• Fowler XP, Eid MA, Barnes JA, et al. Trends of concomitant diabetes and peripheral artery disease and lower extremity amputation in us medicare patients, 2007 to 2019. Circ Cardiovasc Qual Outcomes. 2023;16(6):e009531. doi:10.1161/CIRCOUTCOMES.122.009531
   PubMed Web of Science ®Google Scholar
• Hussain MA, Al-Omran M, Salata K, et al. Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease. Cmaj. 2019;191(35):E955–E961. doi:10.1503/cmaj.190134
   PubMed Web of Science ®Google Scholar
• Pizzimenti M, Meyer A, Charles AL, et al. Sarcopenia and peripheral arterial disease: a systematic review. J Cachexia Sarcopenia Muscle. 2020;11(4):866–886. doi:10.1002/jcsm.12587
   PubMed Web of Science ®Google Scholar
• O’Connor S, Blais C, Leclerc J, et al. Evolution in trends of primary lower-extremity amputations associated with diabetes or peripheral artery disease from 2006 to 2019. Can J Cardiol. 2023;39(3):321–330. doi:10.1016/j.cjca.2022.11.010
   PubMed Web of Science ®Google Scholar
• Takahara M, Iida O, Kohsaka S, et al. Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases. Cardiovasc Diabetol. 2019;18(1):155. doi:10.1186/s12933-019-0955-5
   PubMed Web of Science ®Google Scholar
• Hess CN, Fu JW, Gundrum J, et al. Diabetes mellitus and risk stratification after peripheral artery revascularization. J Am Coll Cardiol. 2021;77(22):2867–2869. doi:10.1016/j.jacc.2021.04.011
   PubMed Web of Science ®Google Scholar
• Alnima T, Meijer RI, Spronk HMH, et al. Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease. Cardiovasc Diabetol. 2023;22(1):257. doi:10.1186/s12933-023-01990-6
   PubMed Web of Science ®Google Scholar
• Sonaglioni A, Barlocci E, Adda G, et al. The impact of short-term hyperglycemia and obesity on biventricular and biatrial myocardial function assessed by speckle tracking echocardiography in a population of women with gestational diabetes mellitus. Nutr Metab Cardiovasc Dis. 2022;32(2):456–468. doi:10.1016/j.numecd.2021.10.011
   PubMed Web of Science ®Google Scholar
• Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766
   PubMed Web of Science ®Google Scholar
• Yang W, Jiang W, Guo S. Regulation of macronutrients in insulin resistance and glucose homeostasis during Type 2 diabetes mellitus. Nutrients. 2023;15(21):4671. doi:10.3390/nu15214671
   PubMed Web of Science ®Google Scholar
• Love KM, Liu Z. DPP4 activity, hyperinsulinemia, and atherosclerosis. J Clin Endocrinol Metab. 2021;106(6):1553–1565. doi:10.1210/clinem/dgab078
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiao S, Jiao X, et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018. Cardiovasc Diabetol. 2023;22(1):279. doi:10.1186/s12933-023-02030-z
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(Supplement_1):S14–S31. doi:10.2337/dc20-S002
   PubMed Web of Science ®Google Scholar
• Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American heart association. Circulation. 2021;144(9):e171–e191. doi:10.1161/CIR.0000000000001005
   PubMed Web of Science ®Google Scholar
• Petrelli A, Cugnata F, Carnovale D, et al. HOMA-IR and the Matsuda index as predictors of progression to type 1 diabetes in autoantibody-positive relatives. Diabetologia. 2024;67(2):290–300. doi:10.1007/s00125-023-06034-y
   PubMed Web of Science ®Google Scholar
• Che B, Zhong C, Zhang R, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34. doi:10.1186/s12933-023-01762-2
   PubMed Web of Science ®Google Scholar
• Liu Y, Chang L, Wu M, et al. Triglyceride glucose index was associated with the risk of peripheral artery disease. Angiology. 2022;73(7):655–659. doi:10.1177/00033197211070644
   PubMed Web of Science ®Google Scholar
• Zhao S, Yu S, Chi C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95. doi:10.1186/s12933-019-0898-x
   PubMed Web of Science ®Google Scholar
• Pala AA, Urcun YS. Relationship of triglyceride-glucose index with chronic limb-threatening ischemia in lower extremity peripheral artery disease. Vascular. 2022;30(3):455–462. doi:10.1177/17085381211018332
   PubMed Web of Science ®Google Scholar
• Gao JW, Hao QY, Gao M, et al. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021;20(1):126. doi:10.1186/s12933-021-01319-1
   PubMed Web of Science ®Google Scholar
• Rosengren A. Obesity and cardiovascular health: the size of the problem. Eur Heart J. 2021;42(34):3404–3406. doi:10.1093/eurheartj/ehab518
   PubMed Web of Science ®Google Scholar
• Iacobellis G. Epicardial fat links obesity to cardiovascular diseases. Prog Cardiovasc Dis. 2023;78:27–33. doi:10.1016/j.pcad.2023.04.006
   PubMed Web of Science ®Google Scholar
• Lee J, Kim B, Kim W, et al. Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population. Sci Rep. 2021;11(1):2366. doi:10.1038/s41598-021-82053-2
   PubMed Web of Science ®Google Scholar
• Yan S, Wang D, Jia Y. Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study. Hormones. 2023;22(2):331–341. doi:10.1007/s42000-023-00448-4
   PubMedGoogle Scholar
• Lim J, Kim J, Koo SH, et al. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14(3):e0212963. doi:10.1371/journal.pone.0212963
   PubMed Web of Science ®Google Scholar
• Ren J, Wu NN, Wang S, et al. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101(4):1745–1807. doi:10.1152/physrev.00030.2020
   PubMed Web of Science ®Google Scholar
• Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi:10.1186/s12933-018-0762-4
   PubMed Web of Science ®Google Scholar
• Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003–2018. Cardiovasc Diabetol. 2024;23(1):8. doi:10.1186/s12933-023-02115-9
   PubMed Web of Science ®Google Scholar
• Nogueira MDA, Braga RAM, Manios Y, et al. New indices in predicting cardiometabolic risk and its relation to endothelial dysfunction in adolescents: the HELENA study. Nutr Metab Cardiovasc Dis. 2023;33(5):1037–1048. doi:10.1016/j.numecd.2023.01.015
   PubMed Web of Science ®Google Scholar
• Wang X, Shen Y, Shang M, et al. Endothelial mechanobiology in atherosclerosis. Cardiovasc Res. 2023;119(8):1656–1675. doi:10.1093/cvr/cvad076
   PubMed Web of Science ®Google Scholar